Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemo-Hormonal Therapy vs Androgen Ablation in Metastatic Prostate Cancer
NCT00002855Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 1996
- Primary completion
- Jun 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of doxorubicin, ketoconazole, vinblastine, estramustine in prostate cancer (PCa), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 1996; status: completed.
02
Drugs
doxorubicinketoconazolevinblastineestramustine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00002855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002855.